Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Annual Report of the 2022 National Clinical Database: Decade-Long Trends and Current Status of Gastroenterological Surgery in Japan.

Annals of gastroenterological surgery·2026
Same author

Visual Recovery After Surgery in Epiretinal Membrane Eyes with Retinal Nerve Fiber Layer Schisis and Internal Limiting Membrane Tear.

Ophthalmology. Retina·2026
Same author

Analytical comparison of two commercially available feline serum amyloid A assays using residual clinical plasma samples.

The Journal of veterinary medical science·2026
Same author

Analysis of Formimidoyltransferase Cyclodeaminase as a Potential Prognostic Biomarker and Therapeutic Target in Colorectal Cancer.

Cancer genomics & proteomics·2026
Same author

ASO Visual Abstract: High Serum IgA Identifies Poor Responders to Immune Checkpoint Inhibitors in Patients with Unresectable Esophageal Squamous Cell Carcinoma.

Annals of surgical oncology·2026
Same author

Six key elements for effective coordination in home-based care for older adults with cancer in Japan: A qualitative interview study.

Journal of geriatric oncology·2026

Related Experiment Video

Updated: Jul 9, 2026

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
11:43

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Published on: December 30, 2016

Exploration of Lipid Mediators for Therapeutic Monitoring of Pancreatic Cancer Patients.

Nobuhiko Nakagawa1, Masamichi Hayashi2, Daigo Kobayashi1

  • 1Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Anticancer Research
|March 28, 2025
PubMed
Summary

Low levels of lysophosphatidylcholine (LPC) in blood exosomes may indicate a worse prognosis for pancreatic cancer patients. These exosomal lipid biomarkers could help monitor disease progression during treatment.

Keywords:
Lysophosphatidylcholinelipidomicslysophosphatidylethanolaminepancreatic cancer

More Related Videos

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

CT-guided Preoperative Localization of Pulmonary Nodules Using a Glucose Test and Tissue Adhesive
02:37

CT-guided Preoperative Localization of Pulmonary Nodules Using a Glucose Test and Tissue Adhesive

Published on: January 30, 2026

Related Experiment Videos

Last Updated: Jul 9, 2026

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging
11:43

Hyperpolarized 13C Metabolic Magnetic Resonance Spectroscopy and Imaging

Published on: December 30, 2016

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
10:28

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

CT-guided Preoperative Localization of Pulmonary Nodules Using a Glucose Test and Tissue Adhesive
02:37

CT-guided Preoperative Localization of Pulmonary Nodules Using a Glucose Test and Tissue Adhesive

Published on: January 30, 2026

Area of Science:

  • Biochemistry
  • Oncology
  • Biomarker Discovery

Background:

  • Multimodal treatment is standard for pancreatic cancer, but protein markers are insufficient for real-time monitoring.
  • Exosomes, containing biological mediators, offer potential for novel biomarker detection.
  • This study investigates exosomal lipid biomarkers for pancreatic ductal adenocarcinoma (PDAC) management.

Purpose of the Study:

  • To identify novel exosomal lipid biomarkers for pancreatic cancer.
  • To assess the utility of these biomarkers in monitoring disease status and predicting treatment outcomes.
  • To evaluate lysophosphatidylcholine (LPC) levels in exosomes of PDAC patients.

Main Methods:

  • Serum exosome-derived lipid samples from PDAC patients and healthy controls were analyzed using liquid chromatography-mass spectrometry (LC-MS).
  • Candidate biomarkers were identified and validated in independent patient cohorts, including those undergoing multimodal treatment.
  • Longitudinal samples were used to track biomarker levels over time in relation to disease progression.

Main Results:

  • Nontarget LC-MS revealed significantly decreased lysophosphatidylcholine (LPC) expression in PDAC patients compared to controls.
  • Lower levels of LPC (16:0) and LPC (18:1) were consistently observed in relapsed cases over time.
  • Pre-treatment low LPC levels correlated with histological lymphatic invasion and predicted unfavorable progression-free survival (PFS).

Conclusions:

  • Initially low exosomal LPC levels in PDAC patients are associated with unfavorable PFS.
  • Exosomal lipid markers, specifically LPC, show potential as indicators for monitoring pancreatic cancer patients during multimodal therapy.
  • This research highlights the role of exosomal lipids in understanding and managing pancreatic cancer progression.